Opportunity
Simpler Grants.gov #RFA-OH-26-015
CDC-ERA R21 Grants for World Trade Center Health Program Research
Buyer
Centers for Disease Control and Prevention - ERA
Posted
October 15, 2023
Respond By
February 12, 2026
Identifier
RFA-OH-26-015
NAICS
541715
This opportunity invites applications for exploratory and developmental research grants (R21) from the Centers for Disease Control and Prevention - ERA, focused on the World Trade Center Health Program. - Government Buyer: - Centers for Disease Control and Prevention (CDC) - ERA - Products/Services Requested: - Exploratory/Developmental Research Grants (R21) - Research must address diagnostic or treatment uncertainty for individuals monitored or treated under the James Zadroga 9/11 Health and Compensation Act - Projects should be early-stage, with minimal or no preliminary data - Up to 60 awards anticipated - Minimum award amount: $365,000 - Total available funding: up to $30,000,000 - Unique/Notable Requirements: - Research must be relevant to the World Trade Center Health Program - Eligible applicants include government entities, educational institutions, businesses, and nonprofits - Non-U.S. entities and foreign components are not eligible - No cost sharing or matching required - No specific OEMs or vendors are mentioned, as this is a research grant opportunity, not a product procurement.
Description
The World Trade Center (WTC) Health Program supports exploratory and developmental research projects (R21) addressing diagnostic or treatment uncertainty for individuals under the James Zadroga 9/11 Health and Compensation Act. The program encourages early-stage research to assess feasibility of new investigation areas that could enhance treatment and diagnostic practices. Projects may lead to breakthroughs or new clinical interventions, techniques, or methodologies. Applicants should propose research with minimal or no preliminary data.